Merck & Co. Market Cap

Merck & Co. has a market cap or net worth of $361.97 billion as of November 6, 2026. It is the 37th most valuable company in the world and the 26th biggest in the United States. Its market cap has increased by 72.81% in one year.

Market Cap

361.97B

Enterprise Value

406.23B

1-Year Change

72.81%

Global Rank

#37

Country Rank

#26 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Merck & Co.'s market cap has increased from $187.00B to $361.97B, an increase of 93.57%. That is a compound annual growth rate of 2.39%.

Market Cap History

Date	Market Cap	% Change
Nov 6, 2026	361.97B	38.55%
Dec 31, 2025	261.26B	3.82%
Dec 31, 2024	251.65B	-8.91%
Dec 29, 2023	276.26B	-1.79%
Dec 30, 2022	281.30B	45.31%
Dec 31, 2021	193.59B	-6.46%
Dec 31, 2020	206.96B	-10.62%
Dec 31, 2019	231.56B	16.54%
Dec 31, 2018	198.69B	29.61%
Dec 29, 2017	153.30B	-5.55%
Dec 30, 2016	162.31B	10.00%
Dec 31, 2015	147.55B	-8.86%
Dec 31, 2014	161.90B	10.71%
Dec 31, 2013	146.24B	17.50%
Dec 31, 2012	124.46B	8.31%
Dec 30, 2011	114.91B	3.49%
Dec 31, 2010	111.03B	44.07%
Dec 31, 2009	77.07B	19.91%
Dec 31, 2008	64.27B	-49.18%
Dec 31, 2007	126.48B	33.62%
Dec 29, 2006	94.66B	36.08%
Dec 30, 2005	69.56B	-2.41%
Dec 31, 2004	71.27B	-30.66%
Dec 31, 2003	102.79B	-19.14%
Dec 31, 2002	127.12B	-4.96%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Eli Lilly and Company	1.22T
Johnson & Johnson	655.56B
AbbVie	509.50B
Novartis AG	310.78B
AstraZeneca	293.41B
Amgen	248.97B
Gilead Sciences	207.84B
Novo Nordisk	179.56B

Market Cap Rankings